期刊文献+

肝动脉化疗栓塞联合射频消融术治疗原发性大肝癌的临床观察 被引量:10

Clinical observation on hepatic arterial chemotherapy embolization combined with radio frequency ablation in treating large liver cancer
下载PDF
导出
摘要 目的分析采用肝动脉化疗栓塞联合射频消融方法对治疗原发性大肝癌的具体临床作用。方法选择2010年8月~2011年9月在我院治疗的54例原发性大肝癌患者作为研究对象,并对治疗后效果进行跟踪。首先使用动脉化疗栓塞法治疗,治疗次数是2~3次;再给予射频消融治疗2~4周。手术后跟踪观察患者的各种临床表现及复发情况等。结果比较手术前后患者情况,手术后54例患者的各种症状有所缓解。甲胎蛋白下降的患者有45例,没发生变化的有3例,升高的有6例。所有病例的平均生存时间是13个月。结论肝动脉化疗栓塞联合射频消融术在治疗不可切除的原发性大肝癌中具有明显的作用,详细结论还需进一步验证。 Objective To analyze the clinica effects of hepatic arterial chemotherapy embolization (TACE) combining with radio therapy ablation (RFA) on the large primary hepatocellular carcinoma (HCC). Methods TACE on 54 cases of large HCC patients hospialized in our hospital from Aug 2010 to September 2011 was performed for 2-3 times, and then RFA was pertormed for 2-4 weeks. The clinical recurrence situation was followed up. Results The clinical symptoms of the 54 cases were relieved. AFP value of 45 cases was decreased. 3 cases was no change and 6 cases increased. The averge survival duration was 13 months. Conclusion TACE combined with RFA has obvous effect on the large HCC that has no chance for surgery. Details still need to be further investigation.
作者 张焱 刘福利
出处 《医学影像学杂志》 2013年第8期1231-1233,共3页 Journal of Medical Imaging
关键词 肝癌 肝动脉化疗栓塞 射频消融 Liver cancer Hepatic arterial chemotherapy embolism Radio frequency ablation
  • 相关文献

参考文献13

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA CancerJ Clin , 2011, 61: 69-90.
  • 2LlovetJ M, Burroughs A, BruixJ. Hepatocellular carcinoma[J]. Lancet, 2003, 362: 1907-1917.
  • 3LlovetJ M, Bruix 1. Novel ad?vancements in the management of hepatocellular carcinoma[J]. J Hepatol, 2008, 48: 520-537.
  • 4Yang B, ZouJ, XiaJ, et al. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation[J]. EurJ Radiol, 2011, 79: 196-200.
  • 5杨秉辉,任正刚.原发性肝癌诊断标准[J].中华肝脏病杂志,2000,8(3):135-135. 被引量:612
  • 6Goldstein HM, Wallace S, AndersonJ H, et al. Transcathe?ter occlusion of abdominal tumors[J]. Radiology, 2006, 120: 539-545.
  • 7Takayasu K, Arii S, Alice I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocel?lular carcinoma in 8510 patients[J]. Gastroenterology, 2006, 131: 461-469.
  • 8Kitamoto M, Imagawa M, Yamada H, et al. Radiofrequency ablationin the treatment of small hepatocellular carcinomas: 'comparison of the radio-frequency effect with and without. che?moembolization[J]. AJR, 2003, 181: 997-1003.
  • 9Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: t.reatment response based on tumor size and mor?phology[J].J Vase Interv Radiol, 2002, 13: 1225-1232.
  • 10靳殿功,孔棣,王桐,李国华.射频消融联合经导管肝动脉栓塞化疗序贯性治疗原发性肝癌[J].中国中西医结合外科杂志,2009,15(2):141-143. 被引量:13

二级参考文献34

共引文献668

同被引文献69

  • 1Angela Falco,Dante Orlando,Roberto Sciarra,Luciano Sergiacomo.A case of biliary gastric fistula following percutaneous radiofrequency thermal ablation of hepatocellular carcinoma[J].World Journal of Gastroenterology,2007,13(5):804-805. 被引量:6
  • 2Yang B ,Zou J ,Xia J ,et al. Risk factors tor recurrence of small hepato- cetlular carcinoma after long-term tollow-up of percutaneous radiofre- quency ablation [ J ]. Eur ~ Radio1,2011,79 (2) : 196-200.
  • 3Zagoria ILl. "Percutaneous RF Interstitial thermal ablation in the treat- ment of hepatic cancer"- a commentary [ J ]. AJR Am J Roentgenol, 2006.187 ( 5 ) ._ 1149-1150.
  • 4Kwan BY ,Kielar AZ ,El-Maraghi RH ,et al. Retrospective review of ef- ficacy of radiofrequency ablation tor treatment of colorectal cancer liver metastases from a Canadian perspective[J].Can Assoc Radiol J, 2014,65 ( 1 ) :77-85.
  • 5Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer : a literature review [ J ]. Gut & Liver,2013,7 ( 1 ) : 1 - 6.
  • 6Ashoori N, Paprnttka P,Trumm C, et al. Muhimodality treatment with conventional transcatheter arterial chemoembolization and radiofre- quency ablation tbr unresectable hepatocellular carcinoma [ J ]. Diges- tion ,2012,85 ( 1 ) : 18-26.
  • 7Peng ZW,Zhang Y J, Chen MS, et al. Radiofl'equeney ablation with or without f transcatheter arterial ehemoembolization in the treatment of hepatocellular carcinoma: a prosptective randomized trial [J]. J Clin0ncol,2012,31 (4) :426-432.
  • 8Lee JM, Jang BK, Lee YJ, et al. Survival outcomes of hepatic re- section compared with transarterial chemoembolization or sor- afenib for hepatocellular carcinoma with portal vein tumor throm- bosis[J]. Clin Mol Hepatol, 2016,22 ( 1 ) : 160-167. DOI: 10. 3350/cmh. 2016.22.1. 160. Epub 2016 Mar 28.
  • 9Geschwind JF, Gholam PM, Goldenberg A, et al. Use of transarte- rial chemoembolization(TACE) and sorafenib in patients with un- resectable hepatocellular carcinoma: US regional analysis of the GIDEON registry [ J ]. Liver Cancer,2016,5 ( 1 ) : 37-46. DOI : 10. 1159/000367757.
  • 10蔺武,李力军.射频消融联合缓释化疗粒子植入治疗结直肠癌肝转移[J].临床荟萃,2009,24(10):869-871. 被引量:4

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部